SCHEMBL1725017

SCHEMBL1725017

CC(C)(C)OC(=O)N1C2CCC1C(c1cncc(N)c1)C2=O

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
PREP P48147 2/20 0.32
ELANE P08246 1/20 0.32
BACE1 P56817 3/20 0.32
CTSD P07339 2/20 0.32
CTSE P14091 1/20 0.32
GPR119 Q8TDV5 3/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
NR1H2 P55055 1/20 0.32
HDAC1 Q13547 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31
ROCK2 O75116 1/20 0.31
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31226444 0.80 NR1H2 (0.36) CHRM2CHRM1CHRM3PREPELANE
SCHEMBL31226345 0.80 NR1H2 (0.36) CHRM2CHRM1CHRM3PREPELANE
SCHEMBL31226731 0.80 NR1H2 (0.36) CHRM2CHRM1CHRM3PREPELANE
SCHEMBL31226929 0.80 NR1H2 (0.36) CHRM2CHRM1CHRM3PREPELANE
SCHEMBL31226406 0.80 NR1H2 (0.36) CHRM2CHRM1CHRM3PREPELANE
SCHEMBL2497881 0.78 CHRNB2 (0.39) CHRM2CHRM1CHRM3GPR119DDB1
SCHEMBL2496002 0.78 CHRNB2 (0.39) CHRM2CHRM1CHRM3GPR119DDB1
SCHEMBL2496001 0.78 CHRNB2 (0.39) CHRM2CHRM1CHRM3GPR119DDB1
SCHEMBL31226273 0.76 PRMT5 (0.40) CHRM2CHRM1CHRM3PREPGPR119
SCHEMBL31226650 0.76 PRMT5 (0.40) CHRM2CHRM1CHRM3PREPGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2494975-A1 Compounds and methods for promoting smoking cessation Research Triangle Institute (US) 2012-09-05 EP disclosed
EP-2404923-A1 7-azabicyclo[2.2.1]heptane derivatives useful for promoting smoking cessation RESEARCH TRIANGLE INSTITUTE (US) 2012-01-11 EP disclosed
US-20090318490-A1 COMPOUNDS AND METHODS FOR PROMOTING SMOKING CESSATION RESEARCH TRIANGLE INSITUTE (US) 2009-12-24 US disclosed
US-7615567-B2 Compounds and methods for promoting smoking cessation RESEARCH TRIANGLE INSTITUTE (US) 2009-11-10 US disclosed
US-20060069111-A1 Compounds and methods for promoting smoking cessation RESEARCH TRIANGLE INSITUTE (US) 2006-03-30 US disclosed
US-20030176434-A1 Compounds and methods for promoting smoking cessation RESEARCH TRIANGLE INSITUTE 2003-09-18 US disclosed
US-6538010-B1 Compounds may be used to treat a variety of other conditions and disease states and reagents for preventing smoking addiction. The present invention also relates to methods and reagents for treating nicotine addiction. RESEARCH TRIANGLE INSTITUTE 2003-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069111-A1 Compounds and methods for promoting smoking cessation BHMT2, CBS, NNMT CHRM2 420/4885CHRM1 711/4885CHRM3 522/4885
US-20090318490-A1 COMPOUNDS AND METHODS FOR PROMOTING SMOKING CESSATION BHMT2, CBS, NNMT CHRM2 420/4885CHRM1 711/4885CHRM3 522/4885
US-20030176434-A1 Compounds and methods for promoting smoking cessation BHMT2, CBS, NNMT CHRM2 420/4885CHRM1 711/4885CHRM3 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.